P115 Quality-of-life analysis in the randomized phase II CLIO trial comparing olaparib with standard chemotherapy in platinum-resistant recurrent ovarian cancer

T Callewaert; A Vanderstichele; E Van Nieuwenhuysen; S Han; N Concin; T Van Gorp; P Berteloot; P Neven; P Busschaert; D Lambrechts; I Vergote

doi:10.1136/ijgc-2019-ESGO.178

Article info

Poster exhibition Day 2

P115 Quality-of-life analysis in the randomized phase II CLIO trial comparing olaparib with standard chemotherapy in platinum-resistant recurrent ovarian cancer

Authors

T Callewaert BGOG and Department of Gynaecology and Obstetrics, University Hospitals Leuven, Leuven Cancer Institute, Leuven, European Union PubMed articles Google scholar articles
A Vanderstichele BGOG and Department of Gynaecology and Obstetrics, University Hospitals Leuven, Leuven Cancer Institute, Leuven, European Union PubMed articles Google scholar articles
E Van Nieuwenhuysen BGOG and Department of Gynaecology and Obstetrics, University Hospitals Leuven, Leuven Cancer Institute, Leuven, European Union PubMed articles Google scholar articles
S Han BGOG and Department of Gynaecology and Obstetrics, University Hospitals Leuven, Leuven Cancer Institute, Leuven, European Union PubMed articles Google scholar articles
N Concin BGOG and Department of Gynaecology and Obstetrics, University Hospitals Leuven, Leuven Cancer Institute, Leuven, European Union PubMed articles Google scholar articles
T Van Gorp BGOG and Department of Gynaecology and Obstetrics, University Hospitals Leuven, Leuven Cancer Institute, Leuven, European Union PubMed articles Google scholar articles
P Berteloot BGOG and Department of Gynaecology and Obstetrics, University Hospitals Leuven, Leuven Cancer Institute, Leuven, European Union PubMed articles Google scholar articles
P Neven BGOG and Department of Gynaecology and Obstetrics, University Hospitals Leuven, Leuven Cancer Institute, Leuven, European Union PubMed articles Google scholar articles
P Busschaert BGOG and Department of Gynaecology and Obstetrics, University Hospitals Leuven, Leuven Cancer Institute, Leuven, European Union PubMed articles Google scholar articles
D Lambrechts Center for Cancer Biology, VIB Laboratory for Translational Genetics, Department of Oncology, KU Leuven, Leuven, Belgium PubMed articles Google scholar articles
I Vergote BGOG and Department of Gynaecology and Obstetrics, University Hospitals Leuven, Leuven Cancer Institute, Leuven, European Union PubMed articles Google scholar articles

Citation

Callewaert T, Vanderstichele A, Van Nieuwenhuysen E, et al

P115 Quality-of-life analysis in the randomized phase II CLIO trial comparing olaparib with standard chemotherapy in platinum-resistant recurrent ovarian cancer

International Journal of Gynecologic Cancer 2019;29:A129-A130.

Publication history

First published November 1, 2019.

Online issue publication

March 03, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password